These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 19901108)

  • 21. CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia.
    Makishima H; Jankowska AM; McDevitt MA; O'Keefe C; Dujardin S; Cazzolli H; Przychodzen B; Prince C; Nicoll J; Siddaiah H; Shaik M; Szpurka H; Hsi E; Advani A; Paquette R; Maciejewski JP
    Blood; 2011 May; 117(21):e198-206. PubMed ID: 21346257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies.
    Lv K; Jiang J; Donaghy R; Riling CR; Cheng Y; Chandra V; Rozenova K; An W; Mohapatra BC; Goetz BT; Pillai V; Han X; Todd EA; Jeschke GR; Langdon WY; Kumar S; Hexner EO; Band H; Tong W
    Genes Dev; 2017 May; 31(10):1007-1023. PubMed ID: 28611190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dasatinib targets B-lineage cells but does not provide an effective therapy for myeloproliferative disease in c-Cbl RING finger mutant mice.
    Duyvestyn JM; Taylor SJ; Dagger SA; Orandle M; Morse HC; Thien CB; Langdon WY
    PLoS One; 2014; 9(4):e94717. PubMed ID: 24718698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia.
    Pérez B; Kosmider O; Cassinat B; Renneville A; Lachenaud J; Kaltenbach S; Bertrand Y; Baruchel A; Chomienne C; Fontenay M; Preudhomme C; Cavé H
    Br J Haematol; 2010 Dec; 151(5):460-8. PubMed ID: 20955399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3q26/EVI1 rearrangement in myelodysplastic/myeloproliferative neoplasms: An early event associated with a poor prognosis.
    Hu Z; Hu S; Ji C; Tang Z; Thakral B; Loghavi S; Medeiros LJ; Wang W
    Leuk Res; 2018 Feb; 65():25-28. PubMed ID: 29288910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia.
    Pérez B; Mechinaud F; Galambrun C; Ben Romdhane N; Isidor B; Philip N; Derain-Court J; Cassinat B; Lachenaud J; Kaltenbach S; Salmon A; Désirée C; Pereira S; Menot ML; Royer N; Fenneteau O; Baruchel A; Chomienne C; Verloes A; Cavé H
    J Med Genet; 2010 Oct; 47(10):686-91. PubMed ID: 20543203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deregulated intracellular signaling by mutated c-CBL in myeloid neoplasms.
    Ogawa S; Shih LY; Suzuki T; Otsu M; Nakauchi H; Koeffler HP; Sanada M
    Clin Cancer Res; 2010 Aug; 16(15):3825-31. PubMed ID: 20547695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CBL mutations in juvenile myelomonocytic leukemia and pediatric myelodysplastic syndrome.
    Shiba N; Kato M; Park MJ; Sanada M; Ito E; Fukushima K; Sako M; Arakawa H; Ogawa S; Hayashi Y
    Leukemia; 2010 May; 24(5):1090-2. PubMed ID: 20357823
    [No Abstract]   [Full Text] [Related]  

  • 29. SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS/MPD-U and MPD.
    Gondek LP; Dunbar AJ; Szpurka H; McDevitt MA; Maciejewski JP
    PLoS One; 2007 Nov; 2(11):e1225. PubMed ID: 18030353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations of c-Cbl in myeloid malignancies.
    Katzav S; Schmitz ML
    Oncotarget; 2015 May; 6(13):10689-96. PubMed ID: 26028666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel oncogenic mutations of CBL in human acute myeloid leukemia that activate growth and survival pathways depend on increased metabolism.
    Fernandes MS; Reddy MM; Croteau NJ; Walz C; Weisbach H; Podar K; Band H; Carroll M; Reiter A; Larson RA; Salgia R; Griffin JD; Sattler M
    J Biol Chem; 2010 Oct; 285(42):32596-605. PubMed ID: 20622007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia.
    Caligiuri MA; Briesewitz R; Yu J; Wang L; Wei M; Arnoczky KJ; Marburger TB; Wen J; Perrotti D; Bloomfield CD; Whitman SP
    Blood; 2007 Aug; 110(3):1022-4. PubMed ID: 17475912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CBL mutations in myeloproliferative neoplasms are also found in the gene's proline-rich domain and in patients with the V617FJAK2.
    Aranaz P; Hurtado C; Erquiaga I; Miguéliz I; Ormazábal C; Cristobal I; García-Delgado M; Novo FJ; Vizmanos JL
    Haematologica; 2012 Aug; 97(8):1234-41. PubMed ID: 22315494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adults with germline CBL mutation complicated with juvenile myelomonocytic leukemia at infancy.
    Muraoka M; Okuma C; Kanamitsu K; Ishida H; Kanazawa Y; Washio K; Seki M; Kato M; Takita J; Sato Y; Ogawa S; Tsukahara H; Oda M; Shimada A
    J Hum Genet; 2016 Jun; 61(6):523-6. PubMed ID: 26911351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progression in Myeloid Neoplasms: Beyond the Myeloblast.
    Faria C; Tzankov A
    Pathobiology; 2024; 91(1):55-75. PubMed ID: 37232015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular and phenotypic diversity of CBL-mutated juvenile myelomonocytic leukemia.
    Hecht A; Meyer JA; Behnert A; Wong E; Chehab F; Olshen A; Hechmer A; Aftandilian C; Bhat R; Choi SW; Chonat S; Farrar JE; Fluchel M; Frangoul H; Han JH; Kolb EA; Kuo DJ; MacMillan ML; Maese L; Maloney KW; Narendran A; Oshrine B; Schultz KR; Sulis ML; Van Mater D; Tasian SK; Hofmann WK; Loh ML; Stieglitz E
    Haematologica; 2022 Jan; 107(1):178-186. PubMed ID: 33375775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VAV1-Cre mediated hematopoietic deletion of CBL and CBL-B leads to JMML-like aggressive early-neonatal myeloproliferative disease.
    An W; Mohapatra BC; Zutshi N; Bielecki TA; Goez BT; Luan H; Iseka F; Mushtaq I; Storck MD; Band V; Band H
    Oncotarget; 2016 Sep; 7(37):59006-59016. PubMed ID: 27449297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clonal selection of 11q CN-LOH and CBL gene mutation in a serially studied patient during MDS progression to AML.
    Barresi V; Palumbo GA; Musso N; Consoli C; Capizzi C; Meli CR; Romano A; Di Raimondo F; Condorelli DF
    Leuk Res; 2010 Nov; 34(11):1539-42. PubMed ID: 20674974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 cases.
    Schnittger S; Bacher U; Alpermann T; Reiter A; Ulke M; Dicker F; Eder C; Kohlmann A; Grossmann V; Kowarsch A; Kern W; Haferlach C; Haferlach T
    Haematologica; 2012 Dec; 97(12):1890-4. PubMed ID: 22733026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited.
    Jerez A; Gondek LP; Jankowska AM; Makishima H; Przychodzen B; Tiu RV; O'Keefe CL; Mohamedali AM; Batista D; Sekeres MA; McDevitt MA; Mufti GJ; Maciejewski JP
    J Clin Oncol; 2012 Apr; 30(12):1343-9. PubMed ID: 22370328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.